PRF1 and colon carcinoma: A perforin-deficient CTL line (pfpCTL) that recognizes mouse colon carcinoma cell line CT26 was used to determine whether these six ceramide analogs are effective in sensitizing CT26 tumor cells to FasL-mediated cytotoxicity of tumor-specific pfpCTLs.